Supporting the call for clinical trials assessing physical exercise and creatine in depression: a response to “Muscle and the mind: The combination of creatine and exercise for depression?”
Sherpa NN. and De Giorgi R., (2025), European Neuropsychopharmacology, 96, 7 - 8
A Survey of Preferences for Sensing Technologies in People with Severe Mental Illness Admitted to an Acute Psychiatric Unit.
Barrera A. et al, (2025), Ann Biomed Eng
The value of mental science: we publish what matters.
Malhi GS. et al, (2025), Br J Psychiatry, 1 - 5
Glucagon-Like Peptide 1 Receptor Agonists and Mental Health: A Systematic Review and Meta-Analysis.
Pierret ACS. et al, (2025), JAMA Psychiatry
Acute angiotensin receptor blockade and mnemonic discrimination in healthy participants.
Prasad D. et al, (2025), J Affect Disord, 375, 293 - 296
Glucagon-like peptide-1 receptor agonists for major neurocognitive disorders.
De Giorgi R. et al, (2025), J Neurol Neurosurg Psychiatry
Preliminary evidence should be treated as such: Response to "Is creatine useful as adjuvant in cognitive-behavioural therapy for depression?".
De Giorgi R. et al, (2025), Eur Neuropsychopharmacol, 93, 15 - 16
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
De Giorgi R. et al, (2025), Nature Mental Health
Real-world effects of antidepressants for depressive disorder in primary care: population-based cohort study.
De Crescenzo F. et al, (2024), Br J Psychiatry, 1 - 10
Efficacy and safety profile of oral creatine monohydrate in add-on to cognitive-behavioural therapy in depression: An 8-week pilot, double-blind, randomised, placebo-controlled feasibility and exploratory trial in an under-resourced area.
Sherpa NN. et al, (2024), Eur Neuropsychopharmacol, 90, 28 - 35
Prevalence of Antidepressant Prescriptions for Community-Dwelling Adults Diagnosed with Depressive Disorder in the UK: A Systematic Review
Francia L. et al, (2024), Psychiatric Quarterly
12-month neurological and psychiatric outcomes of semaglutide use for type 2 diabetes: a propensity-score matched cohort study
DE GIORGI R., (2024), EClinicalMedicine
Treatment coverage for depression in the general Spanish population and the impact of the Covid-19 pandemic
Francia L. et al, (2024), Heliyon, 10, e32594 - e32594
Mortality and adverse events associated with statin use in primary care patients with depression: a real-world, population-based cohort study
DE GIORGI R. et al, (2024), BMJ Mental Health
Organization of Community Mental Health Care in Italy
De Giorgi S. et al, (2024), Sustainable Development Goals Series, Part F3757, 1 - 10
Real-world outcomes of concomitant antidepressant and statin use in primary care patients with depression: a population-based cohort study.
De Giorgi R. et al, (2023), BMC Med, 21
The pharmacological bases for repurposing statins in depression: a review of mechanistic studies.
De Giorgi R. et al, (2023), Transl Psychiatry, 13